Archiv SCREENING

We Have Cleaned the

So What Do We Do Next?

Dr. S. Holland-Crimmin, GlaxoSmithKline, USA

Seite 01

7th World Drug Discovery and Development 2007

Seite 12

Drug Discovery Symposium Assembles Global Experts

Seite 12

Drug Discovery and Development 2007 Conference

Seite 13

Stay in Touch with the Community

A. Chow, Caliper Life Sciences, USA

Seite 14

Intellectual Property

The Landscape of RNAi

C. McKiernan, PhD; K.M. Williams, PhD, J.D.; Edwards Angell Palmer & Dodge, USA

Seite 16

Cell-Based Assays

A Look Back and a Look Forward

K. J. Morrow, Jr., PhD, Newport Biotech Consultants, USA

Seite 22

European Centre for Modern Drug Discovery

C. Claussen, European ScreeningPort; J. Aldag, Evotec; Germany

Seite 25

Experimental and Computational ADMET

Looking Back into the Future

M. Reichman, PhD, Lankenau Institute for Medical Research, USA; W.H.B. Sauer, Merck Serono International, Switzerland

Seite 26

A New Tool for Purification

HPCCC as an Alternative Liquid ChromatographyTechnology

D. Keay, Dr. P. Wood, Dynamic Extractions, United Kingdom

Seite 30

Statistical Process Control

Applications to Vaccine Production

S.N. Deming, Statistical Designs, USA

Seite 34

Triggered Drug Release from Biomaterials

A Step towards Ideal Drug Delivery

Dr. C. P. McCoy, Queen’s University Belfast, United Kingdom

Seite 36

New Developments and Applications in GCPRs

J.-L. Tardieu, Cisbio International, France

Seite 38

Anti-inflammatory Drug Screening

Dr. H. Hundsberger, University of Applied Sciences, Austria

Seite 40

Procurement of Building Blocks

A Bottleneck in Organic Synthesis

ChemBridge, Switzerland

Seite 42

Innovation in Magnetic Particle Bioseparation

Bio-Nobile Oy, Finland

Seite 43